Bristol-Myers Squibb (BMY)
$56.29 0.2%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
5 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Bristol-Myers Squibb, AI stock picks, stock alerts and much more.
BMY AI Stock Analysis
AI stock analysis for BMY is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Bristol-Myers Squibb (BMY) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BMY Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Bristol-Myers Squibb (BMY), currently trading at $56.29, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BMY
-
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide.
-
Symbol
BMY
-
Market
NYSE
-
Industry
Drug Manufacturers - General
-
Market Cap
114.2B
Similar Stocks
 |
Johnson & Johnson JNJ |
$147 0.5% |
5 |
 |
Eli Lilly and Company LLY |
$725.7 4.2% |
7 |
 |
Pfizer PFE |
$26.3 0.7% |
4 |
 |
AbbVie ABBV |
$171.6 1.2% |
6 |
 |
Merck & Company MRK |
$97.92 2.8% |
4 |
News
BMY Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
Instagram Followers
Sign up to access
Youtube Subscribers
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
BMY Financials
BMY Key Metrics
-
Total Revenue
$11.9B
-
Net Income
$1.2B
-
Earnings per Share
$0.6
-
Free cash flow
$5.3B
-
EBITDA
$4.6B
-
EBITDA Ratio
0.384965
-
Total Assets
$93.7B
BMY 2-year Revenue & Income
BMY 2-year Free Cash Flow
BMY Technicals
BMY SMA
BMY RSI
FAQ
What's the current price of Bristol-Myers Squibb (BMY) Stock?
The price of an Bristol-Myers Squibb (BMY) share is $56.29.
What's the market cap of Bristol-Myers Squibb?
The current market cap of Bristol-Myers Squibb is 114.2B.
Should I buy or sell BMY?
Bristol-Myers Squibb exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Bristol-Myers Squibb a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Bristol-Myers Squibb stock. There are several bearish signals and market challenges that could negatively impact Bristol-Myers Squibb's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Bristol-Myers Squibb (BMY) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Bristol-Myers Squibb stock right now, as the outlook appears bearish.
What are some stocks similar to Bristol-Myers Squibb (BMY) that investors often compare it to?
Bristol-Myers Squibb (BMY) is often compared to similar stocks such as Johnson & Johnson, Eli Lilly and Company, Pfizer, AbbVie and Merck & Company.
What is the forecast for Bristol-Myers Squibb's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Bristol-Myers Squibb's stock price to be around $52.82 in 2026. Starting from the current price of $56.29, this represents a 6.2% change in price, indicating a bearish outlook for the stock.
How to buy Bristol-Myers Squibb (BMY) Stock?
Bristol-Myers Squibb stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Bristol-Myers Squibb shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.